1. Home
  2. JANX vs PCH Comparison

JANX vs PCH Comparison

Compare JANX & PCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JANX
  • PCH
  • Stock Information
  • Founded
  • JANX 2017
  • PCH 1903
  • Country
  • JANX United States
  • PCH United States
  • Employees
  • JANX N/A
  • PCH N/A
  • Industry
  • JANX Biotechnology: Pharmaceutical Preparations
  • PCH Real Estate Investment Trusts
  • Sector
  • JANX Health Care
  • PCH Real Estate
  • Exchange
  • JANX Nasdaq
  • PCH Nasdaq
  • Market Cap
  • JANX 3.0B
  • PCH 3.1B
  • IPO Year
  • JANX 2021
  • PCH N/A
  • Fundamental
  • Price
  • JANX $39.88
  • PCH $42.39
  • Analyst Decision
  • JANX Strong Buy
  • PCH Buy
  • Analyst Count
  • JANX 11
  • PCH 5
  • Target Price
  • JANX $83.09
  • PCH $48.20
  • AVG Volume (30 Days)
  • JANX 971.4K
  • PCH 459.0K
  • Earning Date
  • JANX 03-07-2025
  • PCH 01-27-2025
  • Dividend Yield
  • JANX N/A
  • PCH 4.22%
  • EPS Growth
  • JANX N/A
  • PCH N/A
  • EPS
  • JANX N/A
  • PCH 0.20
  • Revenue
  • JANX $13,049,000.00
  • PCH $1,058,432,000.00
  • Revenue This Year
  • JANX $39.66
  • PCH N/A
  • Revenue Next Year
  • JANX N/A
  • PCH $0.66
  • P/E Ratio
  • JANX N/A
  • PCH $214.59
  • Revenue Growth
  • JANX 54.12
  • PCH 3.49
  • 52 Week Low
  • JANX $7.79
  • PCH $37.06
  • 52 Week High
  • JANX $71.71
  • PCH $48.08
  • Technical
  • Relative Strength Index (RSI)
  • JANX 31.06
  • PCH 59.17
  • Support Level
  • JANX $39.95
  • PCH $38.05
  • Resistance Level
  • JANX $47.46
  • PCH $43.06
  • Average True Range (ATR)
  • JANX 3.73
  • PCH 0.87
  • MACD
  • JANX -1.27
  • PCH 0.52
  • Stochastic Oscillator
  • JANX 5.73
  • PCH 86.13

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.

About PCH PotlatchDeltic Corporation

PotlatchDeltic Corp is a REIT that owns and manages forestland in Alabama, Arkansas, Idaho, Minnesota, and Mississippi. Potlach operates in three segments. The timberlands segment covers the planting and harvesting of trees, as well as the construction and maintenance of roads. The wood products segment manufactures and distributes lumber, plywood, and other wood products. The real estate segment covers the sales generated from company-owned timberlands, as well as commercial and residential properties. The timberlands and the wood product segments combined drive the majority of the company's revenue.

Share on Social Networks: